Clinical Trial: An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors

U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951425) titled 'An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors' on April 20.

Brief Summary: This is a Phase l, Open-Label, Dose-escalation Study to Evaluate the Safety, Tolerabilityand Antitumor Activity of TH027 CAR-T Cell lnjection (TH-CART-027) in Subjects With Relapsed or Refractory Solid Tumors.

Study Start Date: June 01

Study Type: INTERVENTIONAL

Condition: Solid Tumors

Intervention: DRUG: TH-CART-027

3+3 dose escalation design: Dose Level 1: 0.3x10^6 CAR+ T cells /kg; Dose Level 2: 1.0x10^6 CAR+ T cells /kg; Dose Level 3: 3.0x10^6 CAR+ T cells /kg

Recruitment Sta...